SP

Shashi Pandey Kant

Director Director DIN 00630591
DIN 00630591 First appointment Dec 2006 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2006
Shareholding value Locked Premium profile

About Shashi Pandey Kant

Data last updated:

Shashi Pandey Kant has 19 years in corporate governance. Formerly with 1 company, such as Cygnusmorpho Biotech India Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 00630591
Primary Designation Director
First Appointment 18 Dec 2006
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director18 Dec 20062006Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cygnusmorpho Biotech India Private Limited
Premium access

Shareholding and investment profile for Shashi Pandey Kant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shashi Pandey Kant

Shashi Pandey Kant has 19 years in corporate governance. Formerly with 1 company, such as Cygnusmorpho Biotech India Private Limited. Engaged in Technology. Contributes to corporate operations.

Shashi Pandey Kant is associated with 0 companies as a director.

Shashi Pandey Kant has expertise in Technology.

Shashi Pandey Kant has 19 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available